 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | LY3316531 / Eli Lilly
Trial completion, Enrollment change: A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis (clinicaltrials.gov) - Aug 7, 2019
P1, N=70, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed | N=102 --> 70
- || LY3316531 / Eli Lilly
Trial completion: A Study of LY3316531 in Healthy Participants (clinicaltrials.gov) - Apr 4, 2019
P1, N=16, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed | N=102 --> 70 Active, not recruiting --> Completed
- || LY3316531 / Eli Lilly
Enrollment change: A Study of LY3316531 in Healthy Participants (clinicaltrials.gov) - Mar 8, 2019
P1, N=16, Active, not recruiting, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed N=70 --> 16
- || LY3316531 / Eli Lilly
Enrollment closed: A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis (clinicaltrials.gov) - Jan 15, 2019
P1, N=102, Active, not recruiting, Sponsor: Eli Lilly and Company
N=70 --> 16 Recruiting --> Active, not recruiting
- || LY3316531 / Eli Lilly
Enrollment closed: A Study of LY3316531 in Healthy Participants (clinicaltrials.gov) - Dec 12, 2018
P1, N=70, Active, not recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Not yet recruiting --> Active, not recruiting
- | LY3316531 / Eli Lilly
New P1 trial: A Study of LY3316531 in Healthy Participants (clinicaltrials.gov) - Aug 1, 2018
P1, N=70, Not yet recruiting, Sponsor: Eli Lilly and Company
- ||| LY3316531 / Eli Lilly
Enrollment open, Trial initiation date: A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis (clinicaltrials.gov) - Feb 5, 2018
P1, N=102, Recruiting, Sponsor: Eli Lilly and Company
Not yet recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Jan 2018 --> Jan 2018
- ||| LY3316531 / Eli Lilly
New P1 trial: A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis (clinicaltrials.gov) - Feb 1, 2018
P1, N=102, Not yet recruiting, Sponsor: Eli Lilly and Company